Local Health Alerts

FDA Warns About Risks Linked to Compounded GLP-1 Drugs: What Patients Need to Know

The FDA has issued recent safety communications about compounded versions of popular GLP-1 drugs such as semaglutide and tirzepatide, warning of dosing errors, ingredient differences, and potential contamination. Here’s what patients and families should understand about the risks, legal limits, and how to…

What’s New in the 2026 Diabetes Care Guidelines — And What It Means for Patients

The American Diabetes Association’s 2026 Standards of Care update national guidance on glucose monitoring, medications, heart and kidney protection, and mental health screening. Here’s what changed — and what it means for patients across the United States.

Weence Health Information and Tools